-
- M. Neumann
- Department of Neuropathology University Hospital of Tübingen Tübingen Germany
-
- I. R. A. Mackenzie
- Department of Pathology University of British Columbia and Vancouver General Hospital Vancouver BC Canada
説明
<jats:p>Frontotemporal dementia (FTD) is a heterogeneous clinical syndrome associated with frontotemporal lobar degeneration (FTLD) as a relatively consistent neuropathological hallmark feature. However, the discoveries in the past decade of many of the relevant pathological proteins aggregating in human FTD brains in addition to several new FTD causing gene mutations underlined that FTD is a diverse condition on the neuropathological and genetic basis. This resulted in a novel molecular classification of these conditions based on the predominant protein abnormality and allows most cases of FTD to be placed now into one of three broad molecular subgroups; FTLD with tau, TAR DNA‐binding protein 43 or FET protein accumulation (FTLD‐tau, FTLD‐TDP and FTLD‐FET respectively). This review will provide an overview of the molecular neuropathology of non‐tau FTLD, insights into disease mechanisms gained from the study of human post mortem tissue as well as discussion of current controversies in the field.</jats:p>
収録刊行物
-
- Neuropathology and Applied Neurobiology
-
Neuropathology and Applied Neurobiology 45 (1), 19-40, 2019-01-21
Wiley